GE Medical Systems Israel Ltd., a prominent subsidiary of General Electric, is headquartered in Israel (IL) and operates extensively across the healthcare technology sector. Founded in the early 2000s, the company has established itself as a leader in medical imaging and diagnostic solutions, contributing significantly to advancements in patient care. Specialising in innovative imaging technologies, GE Medical Systems Israel offers a range of products, including MRI, CT, and ultrasound systems, known for their precision and reliability. The company’s commitment to research and development has led to notable achievements in the field, positioning it as a key player in the global healthcare market. With a strong focus on enhancing diagnostic capabilities, GE Medical Systems Israel continues to push the boundaries of medical technology, ensuring that healthcare providers have access to cutting-edge tools that improve patient outcomes.
How does Ge Medical Systems Israel Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ge Medical Systems Israel Ltd.'s score of 88 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ge Medical Systems Israel Ltd., headquartered in Israel (IL), currently does not report specific carbon emissions data for the most recent year. As a current subsidiary of GE HealthCare Technologies Inc., any climate commitments or emissions data may be inherited from this parent organization. While there are no documented reduction targets or specific emissions figures available for Ge Medical Systems Israel Ltd., it is important to note that the broader corporate family, GE HealthCare Technologies Inc., may have established initiatives and targets related to carbon emissions. However, details on these initiatives, such as Science-Based Targets Initiative (SBTi) commitments or specific reduction achievements, are not provided in the available data. As a subsidiary, Ge Medical Systems Israel Ltd. may align its climate strategies with those of GE HealthCare Technologies Inc., which could include commitments to reduce emissions across various scopes. However, without specific data or targets, the company's individual climate commitments remain unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 137,254,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 2 | 192,207,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 
Ge Medical Systems Israel Ltd.'s Scope 3 emissions, which decreased by 4% last year and decreased by approximately 9% since 2022, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Leased Assets" being the primary emissions source at 68% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ge Medical Systems Israel Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.